Clinical Trial

Genetic, Microbiological and Behavioral Factors in Obesity

Study acronym: OPTIMIZE-GEN
Recruiting
View on ClinicalTrials.gov →
Summary
This study will assess the impact of genetic markers, microbiological (microbiome) and behavioral factors on tolerance, adherence and effectiveness of dual GLP1/GIP RA in the treatment of obesity. 200 consecutive patients who meet all inclusion and none of the exclusion criteria will be enrolled.
Trial Details
NCT Number NCT07650149
Lead Sponsor Jan Kochanowski University
Collaborators: LUX MED Group
Conditions Obesity & Overweight, Obesity, Genetics
Enrollment 200 participants
Start Date 2026-05-23
Primary Completion 2027-05 (estimated)
Study Completion 2028-05 (estimated)
Updated on ClinicalTrials.gov 2026-06-16